Description
| Product Name | CAT.No | Size |
| CA125 | BXL0822A | 96T |
| CA 19.9 | BXL0842A | 96T |
| CA 15-3 | BXL0838A | 96T |
Product Description
The Biorex Diagnostics Cancer Antigen (CA) CLIA Kits are quantitative microplate chemiluminescence immunoassays designed for accurate measurement of key cancer antigens — CA-125, CA-19-9, and CA-15-3 — in human serum. These kits provide a reliable laboratory solution for oncology diagnostics, prognosis, and monitoring of treatment response.
Cancer antigens are glycoproteins expressed in association with tumour activity and are critical biomarkers for detecting and tracking various cancers. CA-125 is primarily associated with ovarian cancer, CA-19-9 with gastrointestinal malignancies such as pancreatic and colorectal cancers, and CA-15-3 with breast cancer. Monitoring these cancer antigens allows clinicians to assess disease progression, evaluate therapeutic response, and detect potential recurrence.
The Biorex Diagnostics Cancer Antigen CLIA Kits use high-sensitivity chemiluminescent immunoassay technology to deliver precise, reproducible, and clinically relevant measurements. The solid-phase microplate format ensures minimal background interference and consistent performance across multiple assay runs and laboratories. These kits are optimised for detecting physiologically and clinically significant antigen concentrations, providing reliable data for both routine diagnostic use and specialised oncology research.
Each kit includes ready-to-use reagents, calibrators, and controls, which streamline workflow, reduce preparation errors, and improve efficiency in laboratory operations. The assays are compatible with standard CLIA microplate readers, making them suitable for high-throughput laboratory environments, hospital testing facilities, and research applications.
Key Features and Benefits
- Quantitative CLIA Microplate Assay: Accurate measurement of cancer antigens CA-125, CA-19-9, and CA-15-3
- High Sensitivity and Specificity: Reliable detection of clinically relevant tumour marker levels
- Excellent Reproducibility: Consistent results across laboratories and multiple assay runs
- Ready-to-Use Components: Streamlines workflow and reduces hands-on time
- Versatile Clinical and Research Use: Supports cancer diagnosis, prognosis, therapy monitoring, and biomarker research
The Biorex Diagnostics Cancer Antigen CLIA Kits are trusted, precise, and efficient tools for laboratories performing tumour marker analysis. By enabling quantitative assessment of cancer antigens, these kits support early detection, informed clinical decision-making, treatment monitoring, and advancement of oncology research, ultimately contributing to improved patient care.
Contact Us for more information.